| Dr Marcus Moody, MD | |
|
2116 Data Park, Hoover, AL 35244-1203 | |
| (205) 733-9595 | |
| (205) 733-9599 |
| Full Name | Dr Marcus Moody |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 28 Years |
| Location | 2116 Data Park, Hoover, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497794945 | NPI | - | NPPES |
| 150987 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YX0905X | Otolaryngology - Otolaryngology/facial Plastic Surgery | 27114 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hoover Ear, Nose And Throat Associates, P.c. | 0840217139 | 3 |
News Archive
RetroSense Therapeutics, LLC, a Michigan-based company, announced that it has executed its exclusive, worldwide option and signed a license agreement for novel gene-therapy approaches for treating blindness developed at Wayne State University's School of Medicine.
Researchers at Baylor College of Medicine have identified a genetic signature combining certain maternal and fetal gene variants that are associated with a higher risk of preeclampsia.
According to a top scientist at China's Centre for Disease Control, a man who died in December infected his father with the deadly H5N1 strain of bird flu before he died.
In an update of the project portfolio, Karo Bio announced, among other things, that the company, in accordance with earlier communicated plans, has submitted an IND application for eprotirome to the American Food and Drug Administration (FDA); that a candidate drug has been nominated within the ER-beta program; and that the company has decided not to initiate further in-house development of KB3305 for the treatment of type 2 diabetes.
› Verified 5 days ago
| Entity Name | Hoover Ear, Nose & Throat Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285700211 PECOS PAC ID: 0840217139 Enrollment ID: O20051026000603 |
News Archive
RetroSense Therapeutics, LLC, a Michigan-based company, announced that it has executed its exclusive, worldwide option and signed a license agreement for novel gene-therapy approaches for treating blindness developed at Wayne State University's School of Medicine.
Researchers at Baylor College of Medicine have identified a genetic signature combining certain maternal and fetal gene variants that are associated with a higher risk of preeclampsia.
According to a top scientist at China's Centre for Disease Control, a man who died in December infected his father with the deadly H5N1 strain of bird flu before he died.
In an update of the project portfolio, Karo Bio announced, among other things, that the company, in accordance with earlier communicated plans, has submitted an IND application for eprotirome to the American Food and Drug Administration (FDA); that a candidate drug has been nominated within the ER-beta program; and that the company has decided not to initiate further in-house development of KB3305 for the treatment of type 2 diabetes.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marcus Moody, MD 2116 Data Park, Hoover, AL 35244-1203 Ph: (205) 733-9595 | Dr Marcus Moody, MD 2116 Data Park, Hoover, AL 35244-1203 Ph: (205) 733-9595 |
News Archive
RetroSense Therapeutics, LLC, a Michigan-based company, announced that it has executed its exclusive, worldwide option and signed a license agreement for novel gene-therapy approaches for treating blindness developed at Wayne State University's School of Medicine.
Researchers at Baylor College of Medicine have identified a genetic signature combining certain maternal and fetal gene variants that are associated with a higher risk of preeclampsia.
According to a top scientist at China's Centre for Disease Control, a man who died in December infected his father with the deadly H5N1 strain of bird flu before he died.
In an update of the project portfolio, Karo Bio announced, among other things, that the company, in accordance with earlier communicated plans, has submitted an IND application for eprotirome to the American Food and Drug Administration (FDA); that a candidate drug has been nominated within the ER-beta program; and that the company has decided not to initiate further in-house development of KB3305 for the treatment of type 2 diabetes.
› Verified 5 days ago
Dr. Edwyn Lee Boyd, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2116 Data Park, Hoover, AL 35244 Phone: 205-733-9595 Fax: 205-733-9599 | |
Dr. Donald Joseph Wittich Jr., M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 2116 Data Park, Hoover, AL 35244 Phone: 205-733-9595 |